423 related articles for article (PubMed ID: 27631728)
1. Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.
Alomar SY; Alkhuriji A; Trayhyrn P; Alhetheel A; Al-Jurayyan A; Mansour L
Immunogenetics; 2017 Feb; 69(2):69-76. PubMed ID: 27631728
[TBL] [Abstract][Full Text] [Related]
2. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population.
Al Omar SY; Mansour L; Dar JA; Alwasel S; Alkhuriji A; Arafah M; Al Obeed O; Christmas S
Genet Test Mol Biomarkers; 2015 Nov; 19(11):617-22. PubMed ID: 26383988
[TBL] [Abstract][Full Text] [Related]
3. Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.
Keating SE; Ní Chorcora C; Dring MM; Stallings RL; O'Meara A; Gardiner CM
Tissue Antigens; 2015 Sep; 86(3):172-7. PubMed ID: 26202659
[TBL] [Abstract][Full Text] [Related]
4. A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia.
Sheereen A; Gaafar A; Iqneibi A; Eldali A; Tabbara KF; Adra C; Al-Hussein K
Mol Vis; 2011; 17():3523-8. PubMed ID: 22219647
[TBL] [Abstract][Full Text] [Related]
5. Association of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Class I Ligand with Recurrent Abortion in Saudi Women.
Mansour L; Alkhuriji A; Babay ZA; Alqadheeb S; Al-Khulaifi F; Al-Talhi R; Alomar S
Genet Test Mol Biomarkers; 2020 Feb; 24(2):78-84. PubMed ID: 31999488
[No Abstract] [Full Text] [Related]
6. Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.
Giebel S; Boratyn-Nowicka A; Karabon L; Jedynak A; Pamula-Pilat J; Tecza K; Kula D; Kowal M; Frydecka I; Grzybowska E
Hum Immunol; 2014 Jun; 75(6):508-13. PubMed ID: 24755350
[TBL] [Abstract][Full Text] [Related]
7. Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.
Sanjeevi S; Sun C; Kanungo A; Sanjeevi CB
Diabet Med; 2016 Jan; 33(1):91-6. PubMed ID: 26031759
[TBL] [Abstract][Full Text] [Related]
8. Disease-association of different killer cell immunoglobulin-like receptors (KIR) and HLA-C gene combinations in reactive arthritis.
Sun HS; Liu DX; Bai YY; Hu NW
Mod Rheumatol; 2019 May; 29(3):531-537. PubMed ID: 29848119
[TBL] [Abstract][Full Text] [Related]
9. KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.
Li JT; Guo C; Li ML; Wei YQ; Hou YF; Jiao YL; Zhao YR; Sun H; Xu J; Cao MF; Feng L; Yu GN; Gao L; Liu YQ; Zhang BC; Zhao JJ; Zhang HQ
Endocr Pract; 2016 Aug; 22(8):935-40. PubMed ID: 27042744
[TBL] [Abstract][Full Text] [Related]
10. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
12. Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).
Osman AE; Eltayeb-ELSheikh N; Mubasher M; Al Harthi H; Alharbi S; Hamza MA; ElGhazali G
Hum Immunol; 2016 Jan; 77(1):110-114. PubMed ID: 26542066
[TBL] [Abstract][Full Text] [Related]
13. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
14. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
15. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
16. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
[TBL] [Abstract][Full Text] [Related]
17. HLA-C C1C2 heterozygosity may protect women bearing the killer immunoglobulin-like receptor AA genotype from spontaneous abortion.
Nowak I; Malinowski A; Tchórzewski H; Barcz E; Wilczyński JR; Banasik M; Gryboś M; Kurpisz M; Luszczek W; Majorczyk E; Wiśniewski A; Senitzer D; Sun JY; Kuśnierczyk P
J Reprod Immunol; 2011 Jan; 88(1):32-7. PubMed ID: 21134695
[TBL] [Abstract][Full Text] [Related]
18. KIR genes and their human leukocyte antigen ligands in the progression to cirrhosis in patients with chronic hepatitis C.
Marangon AV; Silva GF; de Moraes CF; Grotto RM; Pardini MI; de Pauli DS; Sell AM; Visentainer JE; Moliterno RA
Hum Immunol; 2011 Nov; 72(11):1074-8. PubMed ID: 21920398
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
[TBL] [Abstract][Full Text] [Related]
20. Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.
Lee H; Park KH; Park HS; Ryu JH; Lim J; Kim Y; Na GH; Kim DG; Oh EJ
Ann Lab Med; 2017 Jan; 37(1):45-52. PubMed ID: 27834065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
